STAT+: Exclusive: Mystery man gets experimental GLP-1 (opens in new tab)
Giving an individual special access to an experimental obesity drug is highly unusual.
Read the original articleGiving an individual special access to an experimental obesity drug is highly unusual.
Read the original article